$26.61
+0.57 (+2.19%)
Open$26.23
Previous Close$26.04
Day High$26.84
Day Low$25.76
52W High$54.85
52W Low$26.46
Volume—
Avg Volume542.5K
Market Cap1.00B
P/E Ratio—
EPS$-1.00
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-7.4% upside
Current
$26.61
$26.61
Target
$24.64
$24.64
$15.17
$24.64 avg
$37.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 278.73M | 191.72M | 753.50M |
| Net Income | -5,260,496 | -3,256,376 | 117.60M |
| Profit Margin | -1.9% | -1.8% | 15.6% |
| EBITDA | 25.26M | 16.51M | 185.25M |
| Free Cash Flow | — | — | 80.89M |
| Rev Growth | +45.4% | +45.4% | +23.8% |
| Debt/Equity | 4.64 | 4.64 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |